Shibuya Kogyo

Summary

In 1931 was created Shibuya Kogyo, which is appeared as Corporate Investor. The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Kanazawa.

Among the most popular fund investment industries, there are Therapeutics, Medical. Among the various public portfolio startups of the fund, we may underline Promethera Biosciences, Cyfuse Biomedical, Healios K.K The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Shibuya Kogyo, startups are often financed by Shire, Mitsui Global Investment, Boehringer Ingelheim Venture Fund. The meaningful sponsors for the fund in investment in the same round are tella, Shinsei Corporate Investment Limited, Shin Nippon Biomedical Laboratories (SNBL). In the next rounds fund is usually obtained by Sansei Capital Investment, SMBC Venture Capital, SBI Investment.

Opposing the other organizations, this Shibuya Kogyo works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2015. The important activity for fund was in 2018. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations.